Globus Medical, Inc.
GMEDNYSEHealthcareMedical Devices

About Globus Medical

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers musculoskeletal solutions, including spine products, such as traditional fusion implants, and treatment options for motion preservation technologies, and interventional solutions to treat vertebral compression fractures; orthopedic trauma solutions, which includes fracture plating, intramedullary nailing, and regenerative biologic products; hip and knee joint solutions, including modular hip stems and acetabular cups for total hip arthroplasty, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants; and neuromonitoring services, which provides onsite and remote monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries. The company also offers enabling technologies, such as imaging, navigation, and robotics (INR) solutions for assisted surgery, which includes the ExcelsiusGPS platform, a robotic guidance and navigation system for minimally invasive and open procedures with screw and interbody spacer placement applications; Surgimap, a surgical planning software platform; Excelsius3D, a platform combined with ExcelsiusGPS that provides an intraoperative, image-guided robotic navigation solution; ExcelsiusHub, which provides real-time patient array monitoring, tissue sparing drills, and registration flexibility; and ExcelsiusFlex, a total knee arthroplasty robotic solution. Further, it distributes human cell, tissue, and cellular and tissue-based products. The company sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

Company Information

CEOKeith Pfeil
Founded2003
IPO DateAugust 3, 2012
Employees5,300
CountryUnited States
Fiscal YearJanuary - December

Stock Details

ExchangeNYSE (NYSE)
CurrencyUSD - USD
TypeStock
SubtypeCommon Stock
Share ClassClass A Shares

Contact Information

Phone610 930 1800
Address
2560 General Armistead Avenue Audubon, Pennsylvania 19403 United States

Corporate Identifiers

CIK0001237831
CUSIP379577208
ISINUS3795772082
EIN04-3744954
SIC3841

Leadership Team & Key Executives

Keith W. Pfeil
Chief Executive Officer, President and Director
David C. Paul
Co-Founder and Chairman
Kelly G. Huller Esq.
Executive Vice President, General Counsel and Corporate Secretary
Kyle Kline
Senior Vice President and Chief Financial Officer
Brian J. Kearns
Senior Vice President of Business Development and Investor Relations